Trevi Therapeutics, Inc. (NASDAQ:TRVI – Get Free Report) shares reached a new 52-week high on Monday after HC Wainwright ...

The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...

In a report released today, Marc Frahm from TD Cowen maintained a Buy rating on Incyte (INCY – Research Report), with a price target of $88.00.

Shares of weight loss drug developers gained on Wednesday after Roche (OTCQX:RHHBF) announced a multi-billion-dollar deal ...

Cannabix Technologies Inc. (the "Company or Cannabix") reports it is granting 3,375,000 incentive stock options to officers, directors and consultants of the Company, exercisable at $0.54 per share ...

After decades of extensive MISRA C knowledge and leadership, LDRA today announced support for MISRA C:2025, released this week by the MISRA C Working Group. LDRA now enables developers to immediately ...

QRG Capital Management Inc. bought a new position in shares of Elanco Animal Health Incorporated (NYSE:ELAN – Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The ...

Researchers have conducted the first national survey on public awareness and perceptions of food, health, and Food is ...

UA Little Rock honored Emily Wells, the top graduate of 2024, celebrated Arkansas artist Kevin Kresse as the Distinguished Alumnus of the Year, as well as Libby Smith, the longtime award-winning ...

CAMBRIDGE, Mass., February 25, 2025--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy ...

Scholar Rock will present new Phase 3 SAPPHIRE trial data on apitegromab at the 2025 MDA conference, highlighting efficacy ...